
The authors tested the use of repeated cognitive measures to identify those older individuals who experience cognitive decline after administration of a centrally acting zzso zzso were 30 medically stable, older volunteers, mean age zzso Administration was a zzso zzso crossover zzso from baseline to zzso 50 zzso or 75 zzso of zzso More patients exhibited significant cognitive zzso after 75 zzso of zzso than after zzso on the zzso Selective Reminding Test Total Recall and the Trails B zzso Data were consistent with models based on prediction zzso zzso zzso using prediction equations can characterize the normal limits of zzso zzso and define excessive cognitive change in elderly subjects, showing promise for use in monitoring patients to identify those who experience mild cognitive toxicity from prescribed zzso 

